Quaisr joins European Innovation Council consortium for digital twins in healthcare

Quaisr is partnering with Multiwave Technologies and the OMICSENS consortium to develop a new omics measurement platform applied to improve non-small cell lung cancer (NSCLC) prognosis. The team will be deploying platform infrastructure for machine-learning pipelines, used by the consortium for analyte identification and quantification.

Full information: External link
Announcement: LinkedIn